The report on global active pharmaceutical ingredients (API) market provides a comprehensive analysis of market size (revenue) for different geographic regions, and forecast for next seven years. The report also offers insights on key market players, market share, market segments, and premium industry trends. It emphasizes on the major drivers, restraints, opportunities and challenges present in the active pharmaceutical ingredients (API) market.
The rise in aging population, advancements in sector of biologics, increasing local manufacturers, and rising prevalence of chronic diseases are some of the major factors driving the active pharmaceutical ingredients (API) market. The rising awareness towards generic drugs, varied government initiatives, and improved market penetration are other factors fuelling the market growth of active pharmaceutical ingredients (API). However, factors such as high cost associated with manufacturing, regulatory landscape, and financial instability are restraining the growth of global active pharmaceutical ingredients (API) market.
The global active pharmaceutical ingredients (API) market is segmented on the basis of manufacturer, drug type, synthesis, classification and therapeutic area. Based on manufacturer, the active pharmaceutical ingredients (API) market is divided into captive and merchant manufacturers. By drug type, the global market is divided into generic drugs and branded drugs. Based on synthesis, the active pharmaceutical ingredients (API) market is divided into synthetic and biological APIs. On the basis of therapeutic area, the API market is segmented into metabolic disorders, cardiovascular disorders, CNS, musculoskeletal diseases, oncology, NSAIDs and others. Based on classification, it is divided into HPAPI and others.
The oncology market segment is expected to account for largest share in the global active pharmaceutical ingredients market in 2016. Factors leading to the large share of this segment include rising incidences and prevalence of cancer, increasing focus of pharmaceutical companies for the novel cancer treatment product development, and rising investments in research activities for novel therapies development like targeted therapies which use anti-body drug conjugates for the cancer treatment.
Based on geography, the global active pharmaceutical ingredients (API) market is segmented into North America, Europe, Asia-Pacific, Latin America, Middle East and Africa. North America is the market leader in the global active pharmaceutical ingredients (API) market, with the U.S. commanding a major market share. This can be credited to the rising incidences of chronic diseases, government focus on increasing adoption of generic drugs, high demand for biologics and specialty drugs, and technological advancements in API manufacturing in this region.
Some of the key players operating in global active pharmaceutical ingredients (API) market include Bristol-Myers Squibb (U.S.), Pfizer, Inc. (U.S.), Merck & Co., Inc. (U.S.), Boehringer Ingelheim (Germany), Novartis International AG (Switzerland), Eli Lilly and Company (U.S.), Sanofi (France), GlaxoSmithKline plc (U.K.),Teva Pharmaceutical Industries Ltd. (Israel), and AbbVie Inc. (U.S.).